Skip to main content
Richard Gralla, MD, Oncology, New Hyde Park, NY

RichardGrallaMD

Oncology • New Hyde Park, NY

Professor, Medicine, A Einstein Coll of Med of Yeshiva Univ

Join to view full profile

Are you Dr. Gralla?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 62 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    450 Lakeville Rd
    New Hyde Park, NY 11042
    Phone+1 516-734-8900
    Fax+1 516-734-8934

Summary

  • Dr. Richard Gralla, MD is an oncologist in New Hyde Park, New York. He is currently licensed to practice medicine in New York and Louisiana. He is affiliated with NYC Health + Hospitals / Jacobi and NYC Health + Hospitals / South Brooklyn Health.

Education & Training

  • Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 1974 - 1977
  • Icahn School of Medicine at Mount Sinai/Morningside/West
    Icahn School of Medicine at Mount Sinai/Morningside/WestResidency, Internal Medicine, 1972 - 1974
  • University of Virginia School of Medicine
    University of Virginia School of MedicineClass of 1972

Certifications & Licensure

  • NY State Medical License
    NY State Medical License 1974 - 2025
  • LA State Medical License
    LA State Medical License 1990 - 2000
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

Authored Content

  • Evaluation of Health-Related Quality of Life and Symptoms in Patients with Advanced Non-Squamous Non-Small Cell Lung Cancer Treated with Nivolumab or Docetaxel in CheckMate 057September 2018

Press Mentions

  • 5 Key Takeaways from Mesothelioma Expert Teleconference
    5 Key Takeaways from Mesothelioma Expert TeleconferenceApril 9th, 2018
  • FDA Approves Rolapitant for CINV
    FDA Approves Rolapitant for CINVSeptember 2nd, 2015

Dr. Richard Gralla, Dr. Richard Gralla, MD, Dr. R Gralla